Learn About Homozygous Familial Hypercholesterolemia (HoFH)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Penn Heart And Vascular Center
Daniel Rader is a Cardiologist and a Medical Genetics provider in Philadelphia, Pennsylvania. Dr. Rader is rated as an Elite provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Homozygous Familial Hypercholesterolemia (HoFH), High Cholesterol, Coronary Heart Disease, Atherosclerosis, and Heart Transplant. Dr. Rader is currently accepting new patients.
Samuel Gidding is a Pediatric Cardiologist in Wilmington, Delaware. Dr. Gidding is rated as an Elite provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Homozygous Familial Hypercholesterolemia (HoFH), Heterozygous Familial Hypercholesterolemia (HeFH), Atherosclerosis, and Hypertension.
John Kastelein practices in Amsterdam, Netherlands. Mr. Kastelein is rated as an Elite expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia (HoFH), High Cholesterol, and Defective Apolipoprotein B-100.
Summary: This multicenter, randomized, placebo-controlled study will evaluate the efficacy and safety of zodasiran subcutaneous (SC) injection in subjects 12 years of age and older with genetically or clinically diagnosed Homozygous familial hypercholesterolemia (HoFH). After completion of the double blind (DB) treatment period subjects will be eligible to continue in the optional open-label extension (OLE...
Summary: This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 2 to \<12 years) with homozygous familial hypercholesterolemia (HoFH) and elevated low density lipoprotein cholesterol (LDLC).